Parsabiv 2.5 mg, Injektionslösung

7680663380010 CH-66338 Injektionslösung
Parsabiv 2.5 mg, Injektionslösung
Parsabiv 2.5 mg, Injektionslösung
Parsabiv 2.5 mg, Injektionslösung
1 / 3
google

Article details

Package size
6
Selling units
6
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
07/07/2021
Summary of Product Characteristics
Français
07/07/2021
Summary of Product Characteristics
Italien
07/07/2021

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.0 MG Substance HBESI

Reimbursement information

Public price
CHF 118.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2018

Authorization holder

Amgen Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
66338
Drug name
Parsabiv, Injektionslösung
Galenic form
LSINJ
ATC Code
H05BX04
Authorization status
Z
Dispensing category
B
First authorization
27/09/2017
Authorization expiration date
31/12/9999
IT Number
07.05.0.
Domain
Human medicine
Field of application
sekundärer Hyperparathyreoidismus (SHPT) bei erwachsenen hämodialysepflichtigen Patienten mit chronischer Nierenerkrankung

Package details

Description (FR)
PARSABIV sol inj 2.5 mg/0.5ml 6 flac 0.5 ml
Description (DE)
PARSABIV Inj Lös 2.5 mg/0.5ml 6 Durchstf 0.5 ml
Market launch
27/09/2017
Narcotic (BTM)
No

Other package sizes (2)

PARSABIV sol inj 5 mg/1ml 6 flac 1 ml
6 DUR
GTIN: 7680663380027
View
PARSABIV sol inj 10 mg/2ml 6 flac 2 ml
6 DUR
GTIN: 7680663380034
View